Middle East And Africa Human Fibrin Glue Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East And Africa Human Fibrin Glue Market Analysis

  • Pharmaceutical
  • Published Report
  • Nov 2021
  • MEA
  • 350 Pages
  • No of Tables: 57
  • No of Figures: 35

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PACKAGE FORM LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 INDUSTRY INSIGHTS

6 REGULATORY ANALYSIS

6.1.1 REGULATION IN U.S.

6.1.2 REGULATION IN EUROPE

6.1.3 REGULATION IN AUSTRALIA

6.1.4 REGULATION IN CANADA

6.1.5 REGULATION IN CHINA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT

7.1.2 INCREASING SURGICAL PROCEDURES

7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE

7.1.4 INCREASE IN THE GERIATRIC POPULATION

7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS

7.2 RESTRAINTS

7.2.1 STRINGENT RULES & REGULATORY

7.2.2 HIGH COST OF PRODUCTS

7.2.3 RISK OF VIRAL INFECTIONS

7.3 OPPORTUNITIES

7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS

7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES

7.3.3 RISING PLASTIC SURGERIES

7.4 CHALLENGES

7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE

7.4.2 LACK OF SKILLED PROFESSIONALS

7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19

8 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET

8.1 IMPACT ON PRICE

8.2 IMPACT ON SUPPLY CHAIN

8.3 IMPACT ON DEMAND

8.4 CONCLUSION

9 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM

9.1 OVERVIEW

9.2 LIQUID

9.2.1 1-2 ML

9.2.2 7-10 ML

9.2.3 3-4 ML

9.2.4 5-6 ML

9.3 PATCH

9.4 OTHERS

10 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 SPECIALTY CLINICS

10.4 AMBULATORY CARE CENTER

10.5 OTHERS

11 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

12 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 WOUND MANAGEMENT

12.3 BURN BLEEDING

12.4 PLASTIC SURGERY

12.5 GENERAL SURGERY

12.6 VASCULAR SURGERIES

12.7 LACERATIONS OF LIVER AND SPLEEN

12.8 CARDIAC SURGERY

12.9 PULMONARY SURGERY

12.1 ORTHOPEDIC SURGERIES

12.11 NEUROSURGERY

12.12 OTHERS

13 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION

13.1 MIDDLE EAST & AFRICA

13.1.1 SAUDI ARABIA

13.1.2 SOUTH AFRICA

13.1.3 U.A.E

13.1.4 ISRAEL

13.1.5 EGYPT

13.1.6 REST OF MIDDLE EAST AND AFRICA

14 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 CSL LIMITED

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 JOHNSON & JOHNSON SERVICES, INC.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 BAXTER

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 HUALAN BIOLOGICAL ENGINEERING, ING

16.4.1 COMPANY SNAPSHOT

16.4.2 COMPANY SHARE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 SHANGHAI RAAS

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 CORZA HEALTH

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 MARQUEE BIOSURGICAL

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 2 MIDDLE EAST AND AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA PATCH IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA HOSPITALS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA AMBULATORY CARE CENTERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA DIRECT TENDER IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA RETAIL SALES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA WOUND MANAGEMENT IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA BURN BLEEDING IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA PLASTIC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA GENERAL SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA VASCULAR SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA LACERATIONS OF LIVER AND SPLEEN IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA CARDIAC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA PULMONARY SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ORTHOPEDIC SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA NEUROSURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 32 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 33 SAUDI ARABIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 34 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 35 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 36 SAUDI ARABIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 37 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 38 SOUTH AFRICA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 39 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 40 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 41 SOUTH AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 42 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 43 U.A.E LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 44 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 45 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 46 U.A.E HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 47 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 48 ISRAEL LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 49 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 50 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 51 ISRAEL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 52 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 53 EGYPT LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

TABLE 54 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 56 EGYPT HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 57 REST OF MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION

FIGURE 11 THE INCREASE IN DEMAND FOR HUMAN FIBRIN GLUES ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 LIQUID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET IN 2022 AND 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET

FIGURE 14 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2021

FIGURE 15 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2022-2029 (USD MILLION)

FIGURE 16 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, CAGR (2022-2029)

FIGURE 17 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, LIFELINE CURVE

FIGURE 18 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2021

FIGURE 19 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 20 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, CAGR (2022-2029)

FIGURE 21 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, LIFELINE CURVE

FIGURE 22 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 23 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 24 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 25 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 26 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2021

FIGURE 27 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 28 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 29 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)

FIGURE 31 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)

FIGURE 32 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 TO 2029)

FIGURE 33 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: BY COUNTRY (2021 TO 2029)

FIGURE 34 MIDDLE EAST & AFRICA HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)

FIGURE 35 MIDDLE EAST AND AFRICA HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)

Frequently Asked Questions

The Human Fibrin Glue Market size will be worth USD 27.09 million by 2029 during the forecast period.
The Human Fibrin Glue Market growth rate is 6.6% during the forecast period.
The Rising disposable incomes and increase in new product development are the growth drivers of the Middle East and Africa Human Fibrin Glue Market.
The package form, application, end user and distribution channel are the factors on which the Middle East and Africa Human Fibrin Glue Market research is based.
The major companies in the Middle East and Africa Human Fibrin Glue Market are Johnson & Johnson Services, Inc., Baxter, CSL Limited, Shanghai RAAS, and Corza Health.